| 2024 | ||
|---|---|---|
| Gross margin | -41,4 k € | |
| EBITDA | -41,7 k € | |
| Operating profit | -41,8 k € | |
| Profit/loss | -42,0 k € | |
| Equity | -22,0 k € | |
| Total assets | 655,5 k € | |
| Cash | 433,6 k € | |
| Debts | 677,4 k € | |
Source: Belgian Official Gazette
Private limited company · Waterloo · incorporated on 23/06/2023
Private limited company loss-making in the latest fiscal year.
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Key indicators
HepaVue Dx is a Private limited company incorporated in 2023. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Waterloo.